SPONSOR

City of Hope Medical Center

Total Trials

Recruiting

Phases

Phase 1, Phase 2, Phase 1, Phase 2, EARLY_Phase 1

Conditions studied: Acute Myeloid Leukemia Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Prostate Cancer Esophageal Squamous Cell Carcinoma Chemotherapy Effect DNA Methylation Breast Carcinoma Multiple Myeloma Recurrent Mycosis Fungoides

City of Hope Medical Center is a clinical research sponsor with 21 registered studies on ClinicalTrials.gov, of which 21 are actively recruiting participants. Research covers conditions including Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Prostate Cancer.

The trial portfolio spans Phase 1, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — City of Hope Medical Center

How many clinical trials has City of Hope Medical Center sponsored?

ClinicalMetric currently tracks 21 clinical trials sponsored by City of Hope Medical Center, of which 21 are actively recruiting participants. These trials cover conditions including Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does City of Hope Medical Center research focus on?

City of Hope Medical Center clinical trials span Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Prostate Cancer, Esophageal Squamous Cell Carcinoma, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a City of Hope Medical Center clinical trial?

To participate in a City of Hope Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all City of Hope Medical Center trials with current recruitment status updated daily.

City of Hope Medical Center

Frequently Asked Questions — City of Hope Medical Center

Clinical Trials by City of Hope Medical Center

8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)

Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma

Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer

A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Circulating Biomarkers in the Development of Type 1 Diabetes

Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer

Denosumab for Type 1 Diabetes

Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes

Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer

Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

AOH1996 for the Treatment of Refractory Solid Tumors

Telehealth Intervention for Ostomy Self-Management